Analyze Diet

Evaluation of the effects of omeprazole on physiological indices of performance of horses during incremental treadmill exercise.

Abstract: Omeprazole is a proton-pump inhibitor recently approved in the United States for the treatment of gastric ulcer disease in horses. A study was designed to determine the effects of omeprazole treatment on the physiological indices of performance of horses during incremental treadmill exercise. In a crossover-design study carried out over 2 weeks, five horses completed standardized incremental exercise tests on a high-speed treadmill either with no treatment or treatment with omeprazole. No statistically significant effects of omeprazole were found on the mean maximum responses for specific oxygen consumption, specific carbon dioxide production, number of steps completed, concentration of plasma lactate, heart rate achieved, or total run time during the standardized incremental exercise protocol. The results indicate omeprazole treatment is unlikely to be associated with marked enhancement of athletic performance.
Publication Date: 2001-10-01 PubMed ID: 19746659
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research evaluates the impact of omeprazole, a medication designed to treat gastric ulcers, on the performance of horses during intensifying treadmill exercise. The experiment did not find any significant effects of the drug on various performance metrics during the exercise protocol, suggesting that omeprazole treatment does not considerably enhance athletic performance in horses.

Introduction and Methodology

  • This study primarily aims to understand the effects of omeprazole, a proton-pump inhibitor commonly used in treating gastric ulcer disease in horses, on their physiological performance indicators during progressive treadmill exercise.
  • The experiment adopted a crossover-design study structure over two weeks, with five horses participating. The horses underwent standardized incremental exercise tests on a high-speed treadmill, either without any treatment or treated with omeprazole.

Performance Parameters

  • The performance parameters evaluated include specific oxygen consumption, specific carbon dioxide production, number of steps completed, plasma lactate levels, maximum heart rate, and total run time during the standardized exercise regimen.
  • These parameters provide insights into the horses’ aerobic and anaerobic capacities, energy expenditure, work output, lactate threshold (indicator of fatigue), and general cardiovascular performance.

Results and Conclusion

  • The study did not find any significant effects of omeprazole on any of the measured physiological indices. This indicates that the use of omeprazole as a treatment for gastric ulcers does not lead to any notable improvement or degradation in the physical performance of horses during increasing intensity exercise.
  • Thus, the findings led the researchers to conclude that using omeprazole as a therapeutic agent in horses is unlikely to contribute significantly to enhancing their athletic performance. This conclusion is crucial as it reassures horse owners, veterinarians, and trainers that the medical treatment of gastric ulcers with omeprazole does not confer an unfair athletic advantage or compromise the horse’s performance.

Cite This Article

APA
Kollias-Baker C, Cox K, Jones J. (2001). Evaluation of the effects of omeprazole on physiological indices of performance of horses during incremental treadmill exercise. Vet Ther, 2(4), 361-369.

Publication

ISSN: 1528-3593
NlmUniqueID: 100936368
Country: United States
Language: English
Volume: 2
Issue: 4
Pages: 361-369

Researcher Affiliations

Kollias-Baker, C
  • K L Maddy Equine Analytical Chemistry Laboratory, University of California, Davis School of Veterinary Medicine Davis, CA 95617, USA.
Cox, K
    Jones, J

      MeSH Terms

      • Animals
      • Carbon Dioxide / metabolism
      • Cross-Over Studies
      • Enzyme Inhibitors / pharmacology
      • Heart Rate / drug effects
      • Horses
      • Lactates / blood
      • Omeprazole / pharmacology
      • Physical Conditioning, Animal / physiology
      • Physical Endurance / drug effects
      • Respiration / drug effects

      Citations

      This article has been cited 4 times.
      1. Luthersson N, Þorgrímsdóttir ÚÝ, Harris PA, Parkin T, Hopster-Iversen C, Bennet ED. Risk Factors for Equine Gastric Ulcer Syndrome Incidence in Adult Icelandic Riding Horses. Animals (Basel) 2023 Nov 14;13(22).
        doi: 10.3390/ani13223512pubmed: 38003130google scholar: lookup
      2. Vokes J, Lovett A, Sykes B. Equine Gastric Ulcer Syndrome: An Update on Current Knowledge. Animals (Basel) 2023 Apr 5;13(7).
        doi: 10.3390/ani13071261pubmed: 37048517google scholar: lookup
      3. Lo Feudo CM, Stucchi L, Conturba B, Stancari G, Zucca E, Ferrucci F. Equine Gastric Ulcer Syndrome affects fitness parameters in poorly performing Standardbred racehorses. Front Vet Sci 2022;9:1014619.
        doi: 10.3389/fvets.2022.1014619pubmed: 36504861google scholar: lookup
      4. Sykes BW, Hewetson M, Hepburn RJ, Luthersson N, Tamzali Y. European College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult Horses. J Vet Intern Med 2015 Sep-Oct;29(5):1288-99.
        doi: 10.1111/jvim.13578pubmed: 26340142google scholar: lookup